Pfizer Obesity Treatment Halted After Clinical Trials

April 14, 2025

Pfizer obesity treatment, a once-promising potential solution for weight management, has faced recent setbacks as the company discontinues its development of danuglipron, an oral drug designed to combat obesity.Announced on Tuesday, this decision follows serious concerns related to a potential drug-induced liver injury experienced by a participant in the clinical trials for obesity.
Read more
hacklink al organik hit grandpashabetbahiscasinojojobetdeneme bonusu veren sitelergrandpashabetgrandpashabetgrandpashabetşişli escortbahiscasinocasibomjojobetbetparkholiganbetaras kargo takipmavibetmavibetBornova escortcasibomcasibom girişgrandpashabetanal sex pornporn sexzbahisceltabetistanbul escortmarsbahis1xbetmeritking